[tBu-d-Gly5]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies

Peptides

Volumn 34, Issue 2, 2012, Pages 404-411

  Ruzza, C ^a   Rizzi, A ^a   Camarda, V ^a   Pulga, A ^a   Marzola, G ^a   Filaferro, M ^b   Novi, C ^b   Ruggieri, V ^b   Marzola, E ^a   Vitale, G ^b   Salvadori, S ^a   Guerrini, R ^a   Calo, G ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Anxiety; Calcium mobilization; Locomotor activity; Neuropeptide S; Righting reflex

Indexed keywords

ANXIOLYTIC AGENT; NEUROPEPTIDE RECEPTOR; NEUROPEPTIDE S; CALCIUM; G PROTEIN COUPLED RECEPTOR; NEUROPEPTIDE; NEUROPEPTIDE S RECEPTOR, RAT; NEUROPEPTIDE S, TERT BUTYLGLY(5); NEUROPEPTIDE S, TERT-BUTYLGLY(5)-; NPSR1 PROTEIN, MOUSE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LOCOMOTION; MALE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RIGHTING REFLEX; TRANQUILIZING ACTIVITY; ANIMAL; CELL STRAIN HEK293; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSFECTION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRASPINAL DRUG ADMINISTRATION; KINETICS; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY; WISTAR RAT;

MUS; RATTUS;

ANIMALS; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; HEK293 CELLS; HUMANS; INFUSIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; KINETICS; MALE; MAZE LEARNING; MICE; MOTOR ACTIVITY; NEUROPEPTIDES; RATS; RATS, WISTAR; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; REFLEX, RIGHTING; TRANSFECTION;

EID: 84859434296     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2012.01.024     Document Type: Article

References (29)

1. J.A. Bouwknecht, and R. Paylor Behavioral and physiological mouse assays for anxiety: a survey in nine mouse strains Behav Brain Res 136 2002 489 501 (Pubitemid 35333265)
2. 5]neuropeptide S J Pharmacol Exp Ther 328 2009 549 555
3. C. Cifani, M.V. Di Bonaventura, N. Cannella, A. Fedeli, R. Guerrini, and G. Calo Effect of neuropeptide S receptor antagonists and partial agonists on palatable food consumption in the rat Peptides 32 2011 44 50
4. D. Dal Ben, I. Antonini, M. Buccioni, C. Lambertucci, G. Marucci, and S. Vittori Molecular modeling studies on the human neuropeptide S receptor and its antagonists ChemMedChem 5 2010 371 383
5. U. Dannlowski, H. Kugel, F. Franke, A. Stuhrmann, C. Hohoff, and P. Zwanzger Neuropeptide-S (NPS) receptor genotype modulates basolateral amygdala responsiveness to aversive stimuli Neuropsychopharmacology 36 2011 1879 1885
6. K. Domschke, A. Reif, H. Weber, J. Richter, C. Hohoff, and P. Ohrmann Neuropeptide S receptor gene - converging evidence for a role in panic disorder Mol Psychiatry 16 2011 938 948
7. J. Donner, R. Haapakoski, S. Ezer, E. Melen, S. Pirkola, and M. Gratacos Assessment of the neuropeptide S system in anxiety disorders Biol Psychiatry 68 2010 474 483
8. D.M. Duangdao, S.D. Clark, N. Okamura, and R.K. Reinscheid Behavioral phenotyping of neuropeptide S receptor knockout mice Behav Brain Res 205 2009 1 9
9. M. Fendt, M. Buchi, H. Burki, S. Imobersteg, B. Ricoux, and T. Suply Neuropeptide S receptor deficiency modulates spontaneous locomotor activity and the acoustic startle response Behav Brain Res 217 2011 1 9
10. D.J. Gottlieb, G.T. O'Connor, and J.B. Wilk Genome-wide association of sleep and circadian phenotypes BMC Med Genet 8 Suppl. 1 2007 S9
11. R. Guerrini, V. Camarda, C. Trapella, G. Calo, A. Rizzi, and C. Ruzza Further studies at neuropeptide S position 5: discovery of novel neuropeptide S receptor antagonists J Med Chem 52 2009 4068 4071
12. R. Guerrini, V. Camarda, C. Trapella, G. Calo, A. Rizzi, and C. Ruzza Synthesis and biological activity of human neuropeptide S analogues modified in position 5: identification of potent and pure neuropeptide S receptor antagonists J Med Chem 52 2009 524 529
13. R. Guerrini, S. Salvadori, A. Rizzi, D. Regoli, and G. Calo Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor Med Res Rev 30 2010 751 777
14. T. Kushikata, H. Yoshida, M. Kudo, S. Salvadori, G. Calo, and K. Hirota The effects of neuropeptide s on general anesthesia in rats Anesth Analg 112 2011 845 849
15. S.K. Leonard, J.M. Dwyer, S.J. Sukoff Rizzo, B. Platt, S.F. Logue, and S.J. Neal Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders Psychopharmacology (Berl) 197 2008 601 611
16. R.R. Neubig, M. Spedding, T. Kenakin, and A. Christopoulos International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology Pharmacol Rev 55 2003 597 606 (Pubitemid 37500521)
17. N. Okamura, S.A. Habay, J. Zeng, A.R. Chamberlin, and R.K. Reinscheid Synthesis and pharmacological in vitro and in vivo profile of 3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68), a selective antagonist of the neuropeptide S receptor J Pharmacol Exp Ther 325 2008 893 901 (Pubitemid 351724341)
18. N. Okamura, K. Hashimoto, M. Iyo, E. Shimizu, A. Dempfle, and S. Friedel Gender-specific association of a functional coding polymorphism in the neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention-deficit/hyperactivity disorder Prog Neuropsychopharmacol Biol Psychiatry 31 2007 1444 1448 (Pubitemid 47302566)
19. A. Pulga, C. Ruzza, A. Rizzi, G. Marzola, and G. Calo Behavioural characterization of mice knockout for the neuropeptide S receptor gene 8th IBRO world congress of neuroscience Florence, Italy, July 14-18 2011 D377
20. K.A. Raczka, N. Gartmann, M.L. Mechias, A. Reif, C. Buchel, and J. Deckert A neuropeptide S receptor variant associated with overinterpretation of fear reactions: a potential neurogenetic basis for catastrophizing Mol Psychiatry 15 2010 1045, 67-74
21. R.K. Reinscheid, Y.L. Xu, N. Okamura, J. Zeng, S. Chung, and R. Pai Pharmacological characterization of human and murine neuropeptide s receptor variants J Pharmacol Exp Ther 315 2005 1338 1345 (Pubitemid 41635423)
22. A. Rizzi, R. Vergura, G. Marzola, C. Ruzza, R. Guerrini, and S. Salvadori Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice Br J Pharmacol 154 2008 471 479 (Pubitemid 351670609)
23. A.L. Roth, E. Marzola, A. Rizzi, M. Arduin, C. Trapella, and C. Corti Structure-activity studies on neuropeptide S: identification of the amino acid residues crucial for receptor activation J Biol Chem 281 2006 20809 20816 (Pubitemid 44115422)
24. C. Ruzza, A. Rizzi, G. Marzola, A. Pulga, R. Guerrini, and G. Calo Locomotor activity stimulatory effects of neuropeptide S in mice are due to selective NPSR activation and display no tolerance liability 8th IBRO world congress of neuroscience Florence, Italy, July 14-18 2011 A337
25. C. Ruzza, A. Rizzi, C. Trapella, M. Pela, V. Camarda, and V. Ruggieri Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68 Peptides 31 2010 915 925
26. G. Vitale, R. Arletti, V. Ruggieri, C. Cifani, and M. Massi Anxiolytic-like effects of nociceptin/orphanin FQ in the elevated plus maze and in the conditioned defensive burying test in rats Peptides 27 2006 2193 2200 (Pubitemid 44189629)
27. G. Vitale, M. Filaferro, V. Ruggieri, S. Pennella, C. Frigeri, and A. Rizzi Anxiolytic-like effect of neuropeptide S in the rat defensive burying Peptides 29 2008 2286 2291 (Pubitemid 50287237)
28. Y.L. Xu, R.K. Reinscheid, S. Huitron-Resendiz, S.D. Clark, Z. Wang, and S.H. Lin Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects Neuron 43 2004 487 497 (Pubitemid 39094676)
29. H. Zhu, M.K. Mingler, M.L. McBride, A.J. Murphy, D.M. Valenzuela, and G.D. Yancopoulos Abnormal response to stress and impaired NPS-induced hyperlocomotion, anxiolytic effect and corticosterone increase in mice lacking NPSR1 Psychoneuroendocrinology 35 2010 1119 1132